EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Three‐Dimensional Airway Reconstruction and Computational Spray Simulation to Guide Bronchoscopic Amphotericin B Delivery in Chronic Pulmonary Aspergillosis: An Exploratory Prospective Cohort Study With Historical Controls

Yonghui Cheng, Hao Zhu, Guoshi Wan, Enguo Chen, Riqing Chen, Chenhui Su, Hong Xu, Xiongjun Fu, Wenwen Kong, Jisong Zhang iD

Mycoses · 2026

DOI: 10.1111/myc.70219 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Mycoses, 2026. Verfasst von Yonghui Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, First People's Hospital of Wuyi County, Jinhua, Zhejiang Province, China. Hauptthemen laut MEDLINE: Amphotericin B, Pulmonary Aspergillosis, Antifungal Agents, Bronchoscopy. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Provincial Medical and Health Science and Technology Plan, Key Research and Development Program of Zhejiang Province, Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To initially evaluate the feasibility and potential clinical value of high‐resolution computed tomography (HRCT)‐based three‐dimensional (3D) airway reconstruction combined with computational spray simulation for guiding bronchoscopic amphotericin B delivery in patients with chronic pulmonary aspergillosis (CPA).

Methods

This multicenter, prospective cohort study with an expanded historical control was conducted. Patients in the prospective reconstruction cohort received HRCT‐based 3D airway reconstruction combined with computational spray simulation to guide bronchoscopic amphotericin B delivery. Historical controls consisted of eligible CPA patients with complete clinical, imaging, treatment, adverse‐event, and 6 month follow‐up data who had received conventional bronchoscopic amphotericin B administration before implementation of the reconstruction‐guided approach.

Results

A total of 10 patients in the reconstruction cohort and 30 historical controls were included. Baseline characteristics were generally comparable between groups, although fatigue was more frequent in the historical control cohort. At 6 months after treatment, the reconstruction cohort showed lower total St. George's respiratory questionnaire (SGRQ) scores than the historical control cohort. And SGRQ scores decreased significantly after treatment in each group, with a decrease of well over four points from baseline. More favourable clinical and radiographic responses and fewer adverse events were observed in the reconstruction cohort.

Conclusion

The integrated reconstruction‐guided strategy may provide a feasible strategy for optimizing bronchoscopic amphotericin B delivery in CPA. Given the historical‐control design, small intervention cohort and potential residual confounding, these preliminary findings should be interpreted as exploratory and require confirmation in larger prospective controlled studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amphotericin BPulmonary AspergillosisAntifungal AgentsBronchoscopyDrug Delivery SystemsHumansProspective StudiesFemaleMaleMiddle AgedTomography, X-Ray ComputedChronic DiseaseAgedImaging, Three-DimensionalAdultTreatment OutcomeHistorically Controlled Study

Stichwörter der Autor:innen

3D airway reconstructionSGRQchronic pulmonary aspergillosiscomputational spray simulation

Substanzen

Amphotericin BAntifungal Agents

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, First People's Hospital of Wuyi County, Jinhua, Zhejiang Province, China.
  • Department of Pulmonary and Critical Care Medicine, Second Hospital of Yuhang District, Hangzhou, Zhejiang Province, China.
  • Department of Pulmonary and Critical Care Medicine, Regional Medical Centre for National Institute of Respiratory Disease, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province,…
  • Broncus Medical, Inc., Hangzhou, Zhejiang Province, China.

ORCID-Profile: Jisong Zhang

Förderung

  • Zhejiang Provincial Medical and Health Science and Technology Plan
  • Key Research and Development Program of Zhejiang Province
  • Zhejiang Provincial Natural Science Foundation of China
  • Medical Education Branch of Chinese Medical Association and National Medical Education Development Center 2023 medical education research project

Zitieren

APA

Cheng, Y., Zhu, H., Wan, G., Chen, E., Chen, R., Su, C., Xu, H., Fu, X., Kong, W., & Zhang, J. (2026). Three‐Dimensional Airway Reconstruction and Computational Spray Simulation to Guide Bronchoscopic Amphotericin B Delivery in Chronic Pulmonary Aspergillosis: An Exploratory Prospective Cohort Study With Historical Controls. Mycoses. https://doi.org/10.1111/myc.70219

Vancouver

Cheng Y, Zhu H, Wan G, Chen E, Chen R, Su C, et al. Three‐Dimensional Airway Reconstruction and Computational Spray Simulation to Guide Bronchoscopic Amphotericin B Delivery in Chronic Pulmonary Aspergillosis: An Exploratory Prospective Cohort Study With Historical Controls. Mycoses. 2026. doi:10.1111/myc.70219

BibTeX
@article{Cheng2026,
  author = {Cheng, Yonghui and Zhu, Hao and Wan, Guoshi and Chen, Enguo and Chen, Riqing and Su, Chenhui and Xu, Hong and Fu, Xiongjun and Kong, Wenwen and Zhang, Jisong},
  title = {Three‐Dimensional Airway Reconstruction and Computational Spray Simulation to Guide Bronchoscopic Amphotericin B Delivery in Chronic Pulmonary Aspergillosis: An Exploratory Prospective Cohort Study With Historical Controls},
  journal = {Mycoses},
  year = {2026},
  doi = {10.1111/myc.70219}
}
Kostenlos starten →